Incidence of sepsis in central venous catheter-bearing patients with hematologic malignancies: Preliminary results

Journal of Vascular Access

Volumn 5, Issue 4, 2004, Pages 168-173

  Nosari, A ^a   Nichelatti, Michele ^a   De Gasperi, A ^a   Nador, G ^a   Anghilieri, M ^a   Mazza, E ^a   Cozzi, P ^a   Mancini, V ^a   Miqueleiz, S ^a   Bettinelli, L ^a   Lucchesini, C ^a   Barate C ^a   Ricci, F ^a   Ciapanna, D ^a   Ravelli, E ^a   Morra, E ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Central venous catheter; Hematologic diseases; Risk factors; Sepsis

Indexed keywords

ANTINEOPLASTIC AGENT; POLYURETHAN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; APHERESIS; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; CANCER CHEMOTHERAPY; CANDIDA ALBICANS; CATHETER INFECTION; CENTRAL VENOUS CATHETER; DRUG DELIVERY SYSTEM; FEMALE; FEVER; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL; HUMAN; INDWELLING CATHETER; LONG TERM CARE; LUNG EMBOLISM; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELOPROLIFERATIVE DISORDER; NEUTROPENIA; RETROSPECTIVE STUDY; RISK FACTOR; SEPSIS; THROMBOSIS;

EID: 23844522331     PISSN: 11297298     EISSN: None     Source Type: Journal    
DOI: 10.1177/112972980400500406     Document Type: Article

References (14)

1. Viot M. Intravenous access: related problems in oncology. Int J Antimicrob Agents 2000; 16: 165-8.
2. Bona RD. Thrombotic complications of central venous catheters in cancer patients. Semin Thromb Hemost 1999; 25: 147-55.
3. Karthaus M, Doellmann T, Klimash T, Krauter J, Heil G, Ganser A. Central venous catheter infections in patients with acute leukemia. Chemotherapy 2002; 48: 154-7.
4. Cortelezzi A, Fracchiolla NS, Maisonneuve P, et al. Central venous catheter-related complications in patients with hematologic malignancies: a retrospective analysis of risk factors and prophylactic measures. Leuk Lymphoma 2003; 1: 1-7.
5. De Bock R, Middelheim AZ. Febrile neutropenia in allogeneic transplantation. Int J Antimicrob Agents 2000; 16: 177-80.
6. Rolston KV. Prediction of neutropenia. Int J Antimicrob Agents 2000; 16: 113-5.
7. Pearson ML. Guideline for prevention of intravascular device-related infections: an overview. The Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1996; 24: 262-77.
8. Pregibon D. Logistic regression diagnostics. Ann Stat 1981; 9: 705-24.
9. Barrera F, Mina B, Huang Y, Groeger JS. Acute complications of central line placement in profoundly thrombocytopenic cancer patients. Cancer 1996; 78: 2025-30.
10. Pagano L, Tacconelli E, Tumbarello M, et al. Bacteriemia in patients with hematological malignancies. Analysis of risk factors, etiological agents and prognostic indicators. Haematologica 1997; 82: 415-9.
11. Carratala J, Niubo R, Fernandez-Sevilla A, et al. Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrob Agents Chemother 1999; 43: 2200-4.
12. Pemberton LB, Lyman B, Lander V, Civinsky J. Sepsis from triple vs single lumen catheters during total parenteral nutrition in surgical or critically ill patients. Arch Surg 1989; 121: 591-4.
13. Gil RT, Kruse JA, Thill-Baharozian MC, Carson RW. Triple vs single lumen central venous catheters. A prospective study in a critically ill population. Arch Intern Med 1989; 149: 1139-43.
14. Raad I. Intravascular catheter-related infections. Lancet 1998; 351: 893-8.